LAZARD ASSET MANAGEMENT LLC - HORIZON PHARMA INVT LTD ownership

HORIZON PHARMA INVT LTD's ticker is and the CUSIP is 44052TAB7. A total of 22 filers reported holding HORIZON PHARMA INVT LTD in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of HORIZON PHARMA INVT LTD
ValueSharesWeighting
Q2 2020$2,012,000
-90.8%
1,040,000
-94.5%
0.00%
-92.5%
Q1 2020$21,945,000
+6.3%
19,000,000
+22.0%
0.04%
+37.9%
Q4 2019$20,653,000
+330.5%
15,580,000
+210.5%
0.03%
+190.0%
Q4 2016$4,797,000
+9.7%
5,017,000
+11.5%
0.01%
+11.1%
Q3 2016$4,373,000
-31.4%
4,500,000
-35.7%
0.01%
-30.8%
Q2 2016$6,378,000
-35.0%
7,000,000
-38.9%
0.01%
-38.1%
Q1 2016$9,811,00011,450,0000.02%
Other shareholders
HORIZON PHARMA INVT LTD shareholders Q2 2020
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 99,100,000$94,914,0003.33%
Lion Point Capital, LP 16,000,000$15,312,0001.38%
SYMPHONY ASSET MANAGEMENT LLC 5,000,000$4,804,0000.96%
LINDEN ADVISORS LP 32,106,000$30,888,0000.95%
OAKTREE CAPITAL MANAGEMENT LP 46,262,000$44,449,0000.62%
Nicholas Investment Partners, LP 8,635,000$8,264,0000.58%
ADVENT CAPITAL MANAGEMENT /DE/ 16,785,000$16,100,0000.34%
CANYON CAPITAL ADVISORS LLC 30,000,000$28,712,0000.32%
SSI INVESTMENT MANAGEMENT LLC 3,250,000$3,110,0000.25%
PALISADE CAPITAL MANAGEMENT, LP 6,278,000$6,031,0000.17%
View complete list of HORIZON PHARMA INVT LTD shareholders